Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000049

Director acquired 2,120 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Scadden David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-20 Exercise or conversion : show line 1 in the form +2,120 17,603 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-06-18 Grant or award : show line 2 in the form Restricted stock units +2,816 2,816 D
2025-06-18 Grant or award : show line 3 in the form Stock options (right to buy) +15,768 15,768 D
2025-06-20 Exercise or conversion : show line 4 in the form Restricted stock units −2,120 0 D
Loading xslF345X05/wk-form4_1750709929.xml…